Editas Medicine News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.07.23	Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas' Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization (PR Newswire)
15.06.23	Editas Medicine Plunges After Pricing 12.5 Mln Share Offering (RTTNews)
09.01.23	Editas Medicine To Reduce Headcount By 20% As Part Of Reprioritization, CSO To Stepdown (RTTNews)
01.03.22	Pre-market Movers: GDRX, TACO, AMBA, MULN, SMLR… (RTTNews)
08.02.22	Pre-market Movers: SLQT, VDLR, AREB, UCL, SOPA… (RTTNews)
13.12.21	Pre-market Movers: ARNA, FHTX, PTPI, BDR, BLUE… (RTTNews)
29.09.21	Pre-market Movers: GOVX, ITRM, GREE, RGS, MTNB… (RTTNews)
12.01.21	BGNE Teams Up With NVS, Editas Slumps Over 15%, LLY's Drug Shines In TRAILBLAZER-ALZ, MESO On Watch (RTTNews)
22.12.20	NantKwest Stock Goes North, QURE's HOPE-B Trial On Hold, EU Greenlights First COVID-19 Vaccine (RTTNews)
10.12.20	Stock Alert: Editas Medicine Touches New 52-week High (RTTNews)
10.12.20	Pre-market Movers In Healthcare Sector: IMMP, SLS, GLSI, PBLA, EDIT, XBIO… (RTTNews)
10.12.20	GTHX Gains On Breast Cancer Trial Data, RCKT Soars On Danon Disease Study Results, XBIO Abuzz (RTTNews)
16.09.20	Pre-market Movers In Healthcare Sector: TLSA, APDN, AVEO, TNXP, ETON… (RTTNews)
23.01.19	6 Top Losers In Healthcare Sector (EDIT, RNN, COCP...) (RTTNews)
30.01.18	AKCA ON The Move, MNLO Makes A Mark, OBSV Looks Ahead With Hope, ARGX Soars (RTTNews)
23.01.18	ARRY Shines A BEACON, So Long To JUNO And BIVV, Exciting Time Ahead For GEMP (RTTNews)
09.01.18	AXON Makes No Headway, BABY Falls, BOLD Subdued, EDIT Slips (RTTNews)
03.01.18	INSY On A High, KIDS Making Giant Strides, No Stopping APVO, EDIT Uncut (RTTNews)
14.11.17	Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team (PR Newswire)
29.09.17	DXCM Falls On CGM Rivalry, ZYNE Firms Up, SPPI In Limelight, Big Day Awaits MNKD (RTTNews)
15.09.17	Biotech Stocks on Investors' Radar -- Clovis Oncology, Dermira, Editas Medicine, and Endocyte (PR Newswire)
18.08.17	Gainers & Losers Of Aug.17: GTHX, CDTX, KMDA, ACHC, EDIT... (RTTNews)
11.08.17	Gainers & Losers Of Aug.10: SGMO, VTVT, EDIT, ACRS, CEMP... (RTTNews)
08.08.17	Gainers & Losers Of Aug.7: MYOK, NXTM, MRNS, GEMP, ZYNE... (RTTNews)
31.07.17	Biotech Stock Performance Review -- Celgene, Cempra, Editas Medicine, and Epizyme (PR Newswire)
08.06.17	Gainers & Losers Of June 7: NH, CRUS, PTCT, ANAB, ACRX... (RTTNews)
31.05.17	Gainers & Losers Of May 30: PTGX, ECYT, NTLA, EDIT, CNCE... (RTTNews)
22.05.17	Research Reports Coverage on Biotech Stocks -- Editas Medicine, Global Blood Therapeutics, Geron, and Infinity Pharma (PR Newswire)
21.03.17	Biotech Stocks on Investors' Radar -- Editas, Intra-Cellular, Aralez Pharma, and Catabasis Pharma (PR Newswire)
15.03.17	FDA Panel Snubs ENDP, Watch Out For TCON, MRK's Keytruda Scores Another Win (RTTNews)
14.03.17	Allergan To Receive Option To License Editas Medicine's Ocular Programs (RTTNews)
14.03.17	Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases (PR Newswire)
16.02.17	ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX (RTTNews)
15.12.16	Flagship Ventures Evolves Name To Flagship Pioneering (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Editas Medicine Inc

Aktien Top/Flop

Meistgelesene Nachrichten